XML 45 R34.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
SEGMENT REPORTING (Tables)
 3 Months Ended
Mar. 31, 2024
Segment Reporting [Abstract]  
Schedule of financial information by reportable segments
Financial information by reportable segment is as follows:
Three Months Ended March 31,
(in thousands)20242023
Net Revenues
Generics, Established Brands, and Other$100,493 $90,456 
Rare Disease36,937 16,330 
Total net revenues$137,430 $106,786 
Segment earnings before interest, taxes, depreciation and amortization (“EBITDA”) and reconciliation to income before income taxes
Generics, Established Brands, and Other$45,306 $38,828 
Rare Disease396 (1,251)
Depreciation and amortization(14,686)(14,700)
Corporate and other unallocated expenses(1)
(10,704)(12,982)
Total operating income 20,312 9,895 
Unrealized gain on investment in equity securities 9,655 — 
Interest expense, net(4,600)(7,696)
Other expense, net(32)(34)
Income Before Income Tax Expense$25,335 $2,165 
______________________________________________
(1)Includes expenses not directly allocated or attributable to a reporting segment, including certain management, legal, accounting, human resources, insurance, and information technology expenses, and are included in selling, general, and administrative expenses in our unaudited interim consolidated statement of operations. This amount also includes the gain on the sale of the Oakville, Ontario site, refer to Note 3 for further information.
Schedule of revenue by geographic operations
The following table depicts the Company’s revenue by geographic operations during the following periods:
(in thousands)Three Months Ended March 31,
Location of Operations20242023
United States$137,430 $106,221 
Canada— 565 
Total Revenue$137,430 $106,786 
Schedule of property, plant and equipment, net by geographic location
(in thousands)March 31, 2024December 31, 2023
United States$46,905 $43,163 
India1,621 1,430 
Total property and equipment, net$48,526 $44,593